Sutent sunitinib regulatory update

Pfizer said it submitted an sNDA to FDA for Sutent sunitinib to treat pancreatic islet cell tumors. The small molecule inhibitor of multiple receptor tyrosine kinases is approved in the U.S. to treat ...